Related Experiment Video

Updated: Jul 14, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

[Cardiac involvement in hemochromatosis]

Sandra Janower1, Olivier Rosmorduc, Ariel Cohen

  • 1Service de cardiologie, Hôpital Saint-Antoine, AP-HP, et Université Pierre et Marie Curie, Paris VI.

Presse Medicale (Paris, France : 1983)
|June 19, 2007
PubMed

Insights

Hemochromatosis can cause heart failure due to iron overload in the heart muscle. Early diagnosis and iron depletion treatments like phlebotomy improve survival by reducing organ damage.

Area of Science:

  • Cardiology
  • Genetics
  • Hematology

Background:

  • Hemochromatosis is a genetic disorder characterized by excessive iron absorption and storage.
  • Cardiac involvement, primarily affecting the myocardium, is a significant complication leading to heart failure.
  • Iron overload in myocytes reduces left ventricular distensibility, a key factor in cardiac dysfunction.

Purpose of the Study:

  • To summarize the cardiac manifestations of hemochromatosis.
  • To outline diagnostic approaches for cardiac involvement.
  • To discuss current treatment strategies and their impact on prognosis.

Main Methods:

  • Diagnosis relies on Doppler echocardiography to assess left ventricular filling and function.
  • Magnetic resonance imaging (MRI) quantifies intrahepatic and intramyocardial iron levels.
  • Genetic analysis helps determine mutation type, influencing symptom onset and organ involvement.

Main Results:

  • Heart failure is the most common cardiac manifestation.
  • Echocardiography reveals abnormal left ventricular filling and systolic dysfunction.
  • MRI provides accurate quantification of iron burden in the liver and heart.

Conclusions:

  • Early diagnosis and iron depletion (phlebotomy for primary, chelation for secondary hemochromatosis) are crucial for improving survival.
  • Management strategies guided by recent guidelines help identify risks, stage disease, and tailor treatment.
  • Reducing organ iron overload, particularly in the liver and myocardium, enhances patient outcomes.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...